A phase 1/2a, multicenter, first-in-human, open-label clinical trial evaluating MDX2001, a tetraspecific T cell engager-expander in patients with advanced solid tumors.

Authors: Ecaterina Elena Dumbrava, Kerry Culm, Lukas Makris, Melissa Lynne Johnson, David Sommerhalder, Jason Timothy Henry, Anna Rachel Minchom, Elena Garralda Cabanas, Min Yang, Monette Cotreau, Anne-Laure Goenaga, Dalia Burzyn, Zhi-Yong Yang, Ronnie Wei, John Mascola, Giovanni Abbadessa, Gary Nabel

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2670

Source: Full article

---

Abstract

TPS2670